<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02642497</url>
  </required_header>
  <id_info>
    <org_study_id>342</org_study_id>
    <nct_id>NCT02642497</nct_id>
  </id_info>
  <brief_title>Local Ketamine Instillation for Postoperative Analgesia</brief_title>
  <official_title>Efficacy of Postoperative Analgesia Offered by Local Ketamine Wound Instillation Following Total Thyroidctomy; a Randomized, Double-blind, Controlled-clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims at exploring the analgesic efficacy, and safety of Ketamine instillation into
      the wound of total thyroidectomy compared to placebo,and to systemic ketamine administration
      (I.M. injection of the same dose) with respect to postoperative VAS, first request of
      analgesia, total opioid consumption, and with respect to possible side effects.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2015</start_date>
  <completion_date type="Actual">December 2016</completion_date>
  <primary_completion_date type="Actual">February 2016</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>total opioid consumption</measure>
    <time_frame>24 hours</time_frame>
    <description>the total amount of morphine consumed during follow up period</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>first request of analgesia</measure>
    <time_frame>24 hours</time_frame>
    <description>time to first request of rescue analgesic drug</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>VAS</measure>
    <time_frame>24 hours</time_frame>
    <description>effect of study drugs on postoperative pain measured by VAS score</description>
  </secondary_outcome>
  <other_outcome>
    <measure>possible side effects</measure>
    <time_frame>24 hours</time_frame>
    <description>occurrence of possible side effects during follow up</description>
  </other_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">90</enrollment>
  <condition>Postoperative Pain</condition>
  <arm_group>
    <arm_group_label>local ketamine group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>intra-wound instillation of ketamine (1 mg/ kg) and normal saline in a total volume of 10 ml dispersed evenly throughout the wound; given after hemostasis and before wound closure, with closure of suction drain tube for 30 min. postoperatively.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>intra-wound instillation of normal saline in a total volume of 10 ml dispersed evenly throughout the wound; given after hemostasis and before wound closure, with closure of suction drain tube for 30 min. postoperatively.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>systemic ketamine group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intra-muscular injection of ketamine at a dose of 1 mg/kg before wound closure.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>intra-wound instillation of ketamine</intervention_name>
    <description>intra-wound instillation of ketamine (1 mg/ kg) and normal saline in a total volume of 10 ml dispersed evenly throughout the wound; given after hemostasis and before wound closure</description>
    <arm_group_label>local ketamine group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>intra-wound instillation of normal saline</intervention_name>
    <description>intra-wound instillation of normal saline in a total volume of 10 ml dispersed evenly throughout the wound; given after hemostasis and before wound closure</description>
    <arm_group_label>control group</arm_group_label>
    <other_name>placebo</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>systemic administration of ketamine</intervention_name>
    <description>intra-muscular administration of ketamine (1 mg/ kg), given before wound closure.</description>
    <arm_group_label>systemic ketamine group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients with thyroid cancer scheduled for total thyroidectomy.

        Exclusion Criteria:

          1. BMI&gt;35

          2. Unstable ischaemic cardiac disease

          3. Increased intracranial pressure

          4. Increased intraocular pressure

          5. Hypersensitivity or allergy to ketamine, local anesthetic, morphine, or other drugs
             used in the study.

          6. Severe psychiatric disease

          7. Unwillingness or inability to use PCA-device

          8. Inability to use VAS scale
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 24, 2015</study_first_submitted>
  <study_first_submitted_qc>December 29, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 30, 2015</study_first_posted>
  <last_update_submitted>January 1, 2017</last_update_submitted>
  <last_update_submitted_qc>January 1, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 4, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Ahmad Mohammad Abd El-Rahman</investigator_full_name>
    <investigator_title>lecturer of anesthesia, ICU, and pain management</investigator_title>
  </responsible_party>
  <keyword>postoperative analgesia</keyword>
  <keyword>ketamine</keyword>
  <keyword>total thyroidectomy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ketamine</mesh_term>
    <mesh_term>Hemostatics</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

